电话:
400-7060-959
传真:
+86 10 56315212-8813
电子邮件:
orders@antibodies-online.cn

CA9 抗体

(Carbonic Anhydrase IX (CA9))
Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. They show extensive diversity in tissue distribution and in their subcellular localization. CA IX is a transmembrane protein and the only tumor-associated carbonic anhydrase isoenzyme known. It is expressed in all clear-cell renal cell carcinoma, but is not detected in normal kidney or most other normal tissues. It may be involved in cell proliferation and transformation. This gene was mapped to 17q21.2 by fluorescence in situ hybridization, however, radiation hybrid mapping localized it to 9p13-p12. [provided by RefSeq, Jul 2008].
CA9 抗体  (AA 37-186) CA9 抗体  (AA 37-186) CA9 抗体 (AA 37-186) (ABIN1724883)

CA9 适用: 人 WB, IHC, ELISA 宿主: 小鼠 Monoclonal 7C4A5 unconjugated

CA9 抗体  (AA 59-414) CA9 抗体  (AA 59-414) CA9 抗体 (AA 59-414) (ABIN7437167)

CA9 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated

CA9 抗体  (AA 37-186) CA9 抗体  (AA 37-186) CA9 抗体 (AA 37-186) (ABIN1724882)

CA9 适用: 人 WB, ELISA, FACS 宿主: 小鼠 Monoclonal 10F7A8 unconjugated

CA9 抗体 by 适用

Find CA9 抗体 for a variety of species such as anti-Human CA9, anti-Mouse CA9, anti-Rat CA9. The species listed below are among those available. Click on a link to go to the corresponding products.

CA9 抗体 by 应用范围

Find CA9 抗体 validated for a specific application such as WB, ELISA, FACS, IHC. Some of the available applications are listed below. Click on a link to go to the corresponding products.

CA9 抗体 by 抗体来源

Find CA9 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.

CA9 抗体 by 抗原表位

Find CA9 抗体 with a specific epitope. The epitopes listed below are among those available. Click on a link to go to the corresponding products.

CA9 抗体 by 克隆形成能力

Find available monoclonal or polyclonal CA9 抗体. Click on a link to go to the corresponding products.

CA9 抗体 by 克隆

Find CA9 抗体 with a specific 克隆. The 克隆 listed below are among those available. Click on a link to go to the corresponding products.

CA9 抗体 by 标记

Find CA9 抗体 with a specific conjugate such as Biotin, PE, APC. The conjugates listed below are among those available. Click on a link to go to the corresponding products.

Popular CA9 抗体

Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity Human
Application WB, IHC, ELISA
Validations
  • (2)
  • (6)
Cat. No. ABIN1724883
Quantity 0.1 mg
Datasheet Datasheet
Reactivity Human
Application WB, IHC, IP, ICC
Validations
  • (6)
Cat. No. ABIN7437167
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application WB, ELISA, FACS
Validations
  • (2)
  • (5)
Cat. No. ABIN1724882
Quantity 0.1 mg
Datasheet Datasheet
Reactivity Human, Mouse, Rat
Application WB, IHC, IF
Validations
  • (4)
Cat. No. ABIN7257299
Quantity 200 μL
Datasheet Datasheet
Reactivity Human
Application WB, IHC, IF
Validations
  • (4)
Cat. No. ABIN6137798
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application WB, ELISA, IF, FACS
Validations
  • (5)
Cat. No. ABIN3028531
Quantity 0.4 mL
Datasheet Datasheet
Reactivity Mouse, Rat
Application WB, ELISA, IHC (p), ICC, IF (cc), IF (p), IHC (fro)
Validations
  • (1)
  • (2)
Cat. No. ABIN752773
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application WB, IF, IHC (p)
Validations
  • (3)
Cat. No. ABIN7250113
Quantity 200 μL
Datasheet Datasheet
Reactivity Human
Application WB, IP
Validations
  • (3)
Cat. No. ABIN3181146
Quantity 100 μL
Datasheet Datasheet
Reactivity Horse, Human
Application WB, IHC, StM
Validations
  • (3)
Cat. No. ABIN6940920
Quantity 100 μg
Datasheet Datasheet
Reactivity Human
Application WB, IF, FACS
Validations
  • (1)
  • (3)
Cat. No. ABIN390041
Quantity 400 μL
Datasheet Datasheet
Reactivity Human
Application WB, ELISA, IP
Validations
  • (2)
Cat. No. ABIN7189143
Quantity 100 μg
Datasheet Datasheet
Reactivity Human
Application IHC, ELISA
Validations
  • (2)
Cat. No. ABIN7139767
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application IHC, ELISA
Validations
  • (2)
Cat. No. ABIN7127380
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application IHC, ELISA
Validations
  • (2)
Cat. No. ABIN7234854
Quantity 200 μL
Datasheet Datasheet

Latest Publications for our CA9 抗体

Chai, Shan, Wang, Zhang, Li, Fang, Song, Liu, Zhang, Yao, Zheng: "Combining DNA Vaccine and AIM2 in H1 Nanoparticles Exert Anti-Renal Carcinoma Effects via Enhancing Tumor-Specific Multi-functional CD8+ T-cell Responses." in: Molecular cancer therapeutics, Vol. 18, Issue 2, pp. 323-334, (2019) (PubMed).

Méhes, Matolay, Beke, Czenke, Jóna, Miltényi, Illés, Bedekovics: "Hypoxia-related carbonic anhydrase IX expression is associated with unfavourable response to first-line therapy in classical Hodgkin's lymphoma." in: Histopathology, Vol. 74, Issue 5, pp. 699-708, (2019) (PubMed).

Guo, Ci, Ahmed, Hua, Soares, Lin, Puca, Vosoughi, Xue, Li, Su, Chen, Nguyen, Liang, Zhang, Xu, Xu, Sheahan, Ba-Alawi, Zhang, Mahamud, Vellanki, Gleave, Bristow, Haibe-Kains, Poirier, Rudin, Tsao et al.: "ONECUT2 is a driver of neuroendocrine prostate cancer. ..." in: Nature communications, Vol. 10, Issue 1, pp. 278, (2019) (PubMed).

Campbell, Dachs, Morrin, Davey, Robinson, Vissers: "Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels." in: BMC cancer, Vol. 19, Issue 1, pp. 307, (2019) (PubMed).

Reijnen, van Weelden, Arts, Peters, Rijken, van de Vijver, Santacana, Bronsert, Bulten, Hirschfeld, Colas, Gil-Moreno, Reques, Mancebo, Krakstad, Trovik, Haldorsen, Huvila, Koskas, Weinberger, Minar et al.: "Poor outcome in hypoxic endometrial carcinoma is related to vascular density. ..." in: British journal of cancer, Vol. 120, Issue 11, pp. 1037-1044, (2019) (PubMed).

Azam, Porrello, Harrison, Leslie, Liu, Waugh, Belanger, Mangala, Lopez-Berestein, Wilson, McCann, Kim, Sood, Liu, Dudley, Pecot: "Quaking orchestrates a post-transcriptional regulatory network of endothelial cell cycle progression critical to angiogenesis and metastasis." in: Oncogene, Vol. 38, Issue 26, pp. 5191-5210, (2019) (PubMed).

Frost, Ciulli, Rocha: "RNA-seq analysis of PHD and VHL inhibitors reveals differences and similarities to the hypoxia response." in: Wellcome open research, Vol. 4, pp. 17, (2019) (PubMed).

Najjar, Menk, Sander, Rao, Karunamurthy, Bhatia, Zhai, Kirkwood, Delgoffe: "Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma." in: JCI insight, Vol. 4, Issue 5, (2019) (PubMed).

Ron, Deán-Ben, Gottschalk, Razansky: "Volumetric Optoacoustic Imaging Unveils High-Resolution Patterns of Acute and Cyclic Hypoxia in a Murine Model of Breast Cancer." in: Cancer research, (2019) (PubMed).

Kitson, Maskell, Sivalingam, Shaw, Crosbie: "Optimization of Window Study Endpoints in Endometrial Cancer." in: Frontiers in oncology, Vol. 9, pp. 428, (2019) (PubMed).

Aliases for CA9 抗体

carbonic anhydrase 9 (CA9) 抗体
carbonic anhydrase 9 (CAH9) 抗体
carbonic anhydrase 9 (Car9) 抗体
CA9 抗体
Ca9 抗体
CAIX 抗体
MN 抗体
MN/CA9 抗体
You are here:
客服